Forecasts data is unavailable for this security.
Consensus recommendation
- 19-Oct-23
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
- 03-Oct-24
Select bar for recommendation details.
Recommendations | 03-Oct-24 | |
---|---|---|
Buy | 8 | |
Outperform | 14 | |
Hold | 5 | |
Sell | 2 | |
Strong Sell | 0 |
Share price forecast
The 26 analysts offering 12 month price targets for AstraZeneca plc have a median target of 14,152.09, with a high estimate of 20,217.05 and a low estimate of 6,095.44. The median estimate represents a 20.57% increase from the last price of 11,738.00.
High | 72.2% | 20,217.05 |
Med | 20.6% | 14,152.09 |
Low | -48.1% | 6,095.44 |
Dividends
Div growth (TTM) | 0.21% |
---|
More ▼
Earnings history & estimates
The next earnings announcement is expected on Nov 12, 2024.
Average growth rate | +0.62% |
Average growth rate | +20.34% |
More ▼
Revenue history & estimates
Average growth rate | +3.20% |
Average growth rate | +17.89% |
More ▼